Eduard Montanya

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

John B. Buse, Julio Rosenstock, Giorgio Sesti et al. · The Lancet · 2009 · 1.5K citations

Open-label Trial, Diabetes Management, Medicine +6

Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology

Mariano Sanz, Antonio Ceriello, Martin Buysschaert et al. · Journal Of Clinical Periodontology · 2017 · 652 citations · Full text

Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial

Richard E. Pratley, Michael A. Nauck, Timothy S. Bailey et al. · The Lancet · 2010 · 586 citations

Metabolic Syndrome, Open-label Trial, Diabetes Management +9

A map of open chromatin in human pancreatic islets

Kyle J. Gaulton, Takao Nammo, Lorenzo Pasquali et al. · Nature Genetics · 2010 · 547 citations · Full text

Chromatin, Chromatin Structure, Chromatin Remodeling +6

Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial

Helena W. Rodbard, Julio Rosenstock, Luís Henrique Santos Canani et al. · Diabetes Care · 2019 · 414 citations · Full text